Stock listing

Frankfurt:2HA Spero Therapeutics, Inc. Aktie

German listing (Frankfurt) of Spero Therapeutics, Inc. · home listing NASDAQ:SPRO

Follow Spero Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · FWB:2HA

€0.902 EUR +0.025 (+2.9%)

Close on Oct 30, 2026

Day range
€0.902 – €0.962 EUROct 30, 2026
Market cap
€52.50M EURAt the close on Oct 30, 2026 · price × 58.23M shares outstanding
Spero Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SPRO · Home$1.04 USD-0.02 (-1.9%)433,563$1.10$1.10$1.03$1.06Close on Nov 2, 2026
Frankfurt:2HA€0.902 EUR+0.025 (+2.9%)—€0.926€0.962€0.902€0.877Close on Oct 30, 2026
Ticker
Frankfurt:2HA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Spero Therapeutics (NASDAQ:SPRO) Q2 2026 Earnings Call

    Wed, Aug 12, 2026 · 5:00 PM ET

    Watch Transcript
  • Spero Therapeutics (NASDAQ:SPRO) Q2 2025 Earnings Call

    Tue, Aug 12, 2025 · 4:30 PM ET

    Watch Transcript
  • Spero Therapeutics (NASDAQ:SPRO) Q4 2024 Earnings Call

    Thu, Mar 27, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

All Spero Therapeutics, Inc. news

Decks

Spero Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 111 in all · newest Nov 2, 2026 · oldest 2019
Calls
16 calls with a replay · 16 with a transcript · latest Aug 12, 2026
Decks
19 decks · latest Aug 12, 2026

Where Spero Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SPRO · Home listingNASDAQUnited StatesUSD
LS Exchange:A2H63FLS ExchangeGermanyEUR
Lang & Schwarz:A2H63FLang & SchwarzGermanyEUR
BOATS:SPROBOATSUnited StatesUSD
gettex:2HAgettexGermanyEUR
Tradegate:2HATradegateGermanyEUR
Dusseldorf:2HADusseldorfGermanyEUR
Frankfurt:2HA · This pageFrankfurtGermanyEUR
Munich:2HAMunichGermanyEUR
Stuttgart:2HAStuttgartGermanyEUR
BIVA:SPROBIVAMexicoMXN
BMV:SPROBMVMexicoMXN

Log in to ask 6ix AI your own questions about Spero Therapeutics, Inc.